Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Return on Sales (2021 - 2025)

PAVmed has reported Return on Sales over the past 5 years, most recently at 0.34% for Q4 2025.

  • For Q4 2025, Return on Sales fell 148.0% year-over-year to 0.34%; the TTM value through Dec 2025 reached 0.25%, down 14.0%, while the annual FY2025 figure was 0.25%, 34.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.34% at PAVmed, up from 12.02% in the prior quarter.
  • Over five years, Return on Sales peaked at 23.28% in Q1 2025 and troughed at 20.54% in Q2 2025.
  • A 5-year average of 1.21% and a median of 0.66% in 2021 define the central range for Return on Sales.
  • On a YoY basis, Return on Sales climbed as much as 2346bps in 2025 and fell as far as -2039bps in 2025.
  • Year by year, Return on Sales stood at 0.66% in 2021, then plummeted by -234bps to 2.19% in 2022, then surged by 92bps to 0.17% in 2023, then soared by 788bps to 1.14% in 2024, then tumbled by -130bps to 0.34% in 2025.
  • Business Quant data shows Return on Sales for PAVM at 0.34% in Q4 2025, 12.02% in Q3 2025, and 20.54% in Q2 2025.